Location History:
- Morpeth, GB (1998 - 2000)
- Essex, GB (2001)
Company Filing History:
Years Active: 1998-2001
Title: The Innovative Contributions of Stephen Brown
Introduction
Stephen Brown is a notable inventor based in Morpeth, GB, recognized for his significant contributions to the field of pharmaceuticals. With a total of three patents to his name, he has made strides in developing formulations that aid in the treatment of cancer tumors. His work exemplifies the intersection of innovation and healthcare, showcasing the importance of research in improving patient outcomes.
Latest Patents
Among his latest patents, the first is related to oxaliplatin formulations. This invention pertains to pharmaceutically stable oxaliplatin solution formulations, detailing methods of use in treating cancer tumors, processes for preparing such formulations, and a method for stabilizing solutions of oxaliplatin. The second patent involves 1,2,4-benzotriazine oxides formulations. This patent discloses aqueous parenteral formulations for treating cancer tumors, which comprise 1,2,4-benzotriazine 1,4-dioxides in a citrate buffer, along with methods for cancer tumor treatment.
Career Highlights
Stephen Brown has had a distinguished career, working with prominent companies in the pharmaceutical industry. He has been associated with Sanofi-Synthelabo and Sanofi Pharmaceuticals, Inc., where he contributed to various innovative projects aimed at enhancing cancer treatment options.
Collaborations
Throughout his career, Stephen has collaborated with notable professionals in the field, including Edward Baker and Nicholas H. Anderson. These collaborations have likely enriched his research and development efforts, leading to impactful innovations.
Conclusion
In summary, Stephen Brown's work in developing pharmaceutical formulations for cancer treatment highlights his role as an influential inventor in the healthcare sector. His patents reflect a commitment to advancing medical science and improving patient care.